[ccpw id="5"]

Home.forex news report3 Analyst-Approved Stocks With Fat Yields That Could Rally 27% or More

3 Analyst-Approved Stocks With Fat Yields That Could Rally 27% or More

-


When people say they’re looking for “dividend stocks,” many investors default to a handful of popular companies like Coca-Cola, Abbott Labs, PepsiCo, and Realty Income as the top suggestions. And I don’t blame them; I’ve written about all these companies before, and yes, they offer very attractive yields, packaged with consistency and reliability.

However, these companies are considered safe, conservative choices.

Some investors might want to make their money work harder. And in that scenario, business development companies (BDCs) offering double-digit yields begin to stand out. Like real estate investment trusts (REITs), BDCs are required by law to distribute at least 90% of their taxable income to shareholders as dividends. That makes them a good choice for high-yield hunting.

So today, I’ll take a look at buy-rated BDCs that offer the highest yields.

I used Barchart’s Stock Screener to find the highest-yielding companies on my watchlist.

  • Annual Dividend Yield % (Forward): Left blank so I can arrange the results based on it.

  • Current Analyst Rating: “Moderate Buy” to “Strong Buy” only, since I’m focusing on companies backed by Wall Street analysts.

  • Number of Analysts: At least 12 analysts covering the stock. This helps ensure the ratings reflect broader analyst coverage rather than just a few opinions.

  • Watchlist:  Finally, I limited the results to companies in my BDC (Business Development Company) watchlist, which includes firms known for generating income primarily through lending to private businesses.

I set the filter, ran the screen, and got 5 results. I then sorted the companies by highest yield.

Now, I’ll cover the top three, starting with:

Trinity Capital Inc is a specialty finance company that provides funding to growing businesses, particularly in the technology and life sciences sectors. It lends capital through venture debt and equipment financing, helping companies scale their operations.

A recent example of this is Trinity Capital’s announcement of a $35 million growth capital loan to Neuros Medical, a private biotech company focused on improving the quality of life for patients who have undergone amputation. Neuros will use the money to scale toward commercialization, including expanding manufacturing, increasing adoption of its technology, and moving closer to generating consistent revenue.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

SPR is Not one Thing

(Oil & Gas 360) – By Greg Barnett, MBA  A forensic look at rules, stock types, and why “tap...

Stocks Pressured by Higher Oil Prices, But Positive Oracle AI News Helps Tech Stocks

The S&P 500 Index ($SPX) (SPY) on Wednesday fell -0.08%, the Dow Jones Industrial Average ($DOWI) (DIA) fell -0.61%, and the Nasdaq 100 Index...

Analysts Discuss Kaiser Aluminum’s (KALU) Shares After Earnings

We recently published 9 Best Aluminum and Aluminum Mining Stocks to Invest In. Kaiser Aluminum Corporation (NASDAQ:KALU) is one of the best...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img